|
Overcoming Cancers Resistant to HER-2 Antibodies (Breaking Tolerance to Antibody-Mediated Immunotherapy)
by
really liked it 4.00 avg rating — 1 rating
|
|
|
Resistance of Cancer Cells to CTL-Mediated Immunotherapy
by
really liked it 4.00 avg rating — 1 rating
|
|
|
Nitric Oxide (Donor/Induced) in Chemosensitization (Volume 1) (Cancer Sensitizing Agents for Chemotherapy, Volume 1)
by
0.00 avg rating — 0 ratings
|
|
|
Hypoxia-induced Tumor Heterogeneity and Immune Evasion: Clinical Interventions (Novel approaches to overcome cancer resistance to conventional therapies)
by
|
|
|
Resistance of Cancer Cells to CTL-Mediated Immunotherapy (Resistance to Targeted Anti-Cancer Therapeutics Book 7)
by
0.00 avg rating — 0 ratings
|
|
|
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance (Resistance to Targeted Anti-Cancer Therapeutics Book 1)
by
0.00 avg rating — 0 ratings
|
|
|
Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy (Cancer Drug Discovery and Development)
by
0.00 avg rating — 0 ratings
|
|
|
Sensitization Of Cancer Cells For Chemo/Immuno/Radio-Therapy
by
0.00 avg rating — 0 ratings
|
|
|
Nitric Oxide and Cancer: Pathogenesis and Therapy
by
0.00 avg rating — 0 ratings
|
|
|
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
by
|
|
|
YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target
by
|
|
|
Prognostic and Therapeutic Applications of Rkip in Cancer
by
|
|
|
New Combination Approaches to Enhance Rituximab-Based Lymphoma Therapies
by
0.00 avg rating — 0 ratings
|
|
|
Overcoming Cancers Resistant to HER-2 Antibodies (Volume 2) (Breaking Tolerance to Antibody-Mediated Immunotherapy, Volume 2)
by
0.00 avg rating — 0 ratings
|
|
|
Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders
by
0.00 avg rating — 0 ratings
|
|
|
Tumor Necrosis Factor/Cachetin and Related Cytokines
by
|
|
|
Nitric Oxide (Donor/Induced) in Chemosensitization (Volume 1) (Cancer Sensitizing Agents for Chemotherapy, Volume 1)
by
|
|
|
Resistance of Cancer Cells to CTL-Mediated Immunotherapy (Resistance to Targeted Anti-Cancer Therapeutics, 7)
by
|
|
|
Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance (Resistance to Targeted Anti-Cancer Therapeutics, 2)
by
0.00 avg rating — 0 ratings
—
published
2013
—
2 editions
|
|
|
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance (Resistance to Targeted Anti-Cancer Therapeutics, 1)
by
0.00 avg rating — 0 ratings
—
published
2013
—
4 editions
|
|
|
Nitric Oxide and Cancer: Pathogenesis and Therapy
by
0.00 avg rating — 0 ratings
—
published
2015
—
5 editions
|
|
|
Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance (Resistance to Targeted Anti-Cancer Therapeutics, 2)
by
0.00 avg rating — 0 ratings
—
published
2013
—
2 editions
|
|
|
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance (Resistance to Targeted Anti-Cancer Therapeutics, 1)
by
0.00 avg rating — 0 ratings
—
published
2013
|
|
|
Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy (Cancer Drug Discovery and Development)
by
0.00 avg rating — 0 ratings
—
published
2010
—
4 editions
|
|
|
Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy (Cancer Drug Discovery and Development)
by
0.00 avg rating — 0 ratings
—
published
2010
|
|
|
Tumor Necrosis Factor: Structure, Mechanism of Action, Role in Disease and Therapy : 2nd International Conference on Tumor Necrosis Factor and Relat
by
0.00 avg rating — 0 ratings
—
published
1990
—
2 editions
|
|
|
Proceedings of the First International Symposium on Physical, Chemical and Biological Properties of Stable Water Clusters: Los Angeles, California 6 December 1997
by
0.00 avg rating — 0 ratings
—
published
1998
|
|
|
Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
by
0.00 avg rating — 0 ratings
—
published
2008
—
7 editions
|
|
|
Chemo-Immunosensitization of Resistant Tumor Cells to Cell Death by Apoptosis 2006
by
0.00 avg rating — 0 ratings
|
|
|
Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Disorders: Third International Conference on Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders
by
0.00 avg rating — 0 ratings
|
|
* Note: these are all the books on Goodreads for this author. To add more books,
click here.